Pet sitting and online pet services company Mad Paws (ASX: MPA) has received a strategic investment of up to $9.25 million from the media house Seven West Media (ASX: SWM). This investment comprises $5.25 million in the initial tranche, including $1.25 million in cash and advertising equivalent to $4 million. This investment will help boost
Read More
Blood cancer patients undergoing chemotherapy could soon have a reduced dependence on blood transfusions thanks to a new clinical study announced, run in partnership between biotech company Syntara (ASX: SNT), the University of Newcastle and the Australasian Leukaemia and Lymphoma Group (ALLG). The Phase 2 clinical study has been backed by a $0.83m grant to
Read More
If you’ve ever had dry itchy eyes, you’re not alone. In just the United States, there are more than 17 million people suffering from dry eye disease (DED) which Cambium Bio is seeking to address through Phase 3 clinical trials that will be assisted by access to new capital as an ASX-listed company upon completion
Read More
The International Bank of Australia could soon be the next challenger bank set to take on the traditional banking landscape with investors keen for a slice of the digital bank which is in the middle of a funding round, most recently raising at a pre-money valuation of $24.7 million. International Bank of Australia (IBoA) was
Read More
Rounding up the first half of FY24, digital real estate portal Domain (ASX: DHG) was relieved to find a positive environment in Sydney and Melbourne, with early signs of improvement in smaller markets. As buyers dealt with higher interest rates and cost of living, demand continued to soar, benefitting real estate companies. Domain reported a
Read More
Heads have turned in biotech circles with an ASX filing confirming that Platinum Asset Management has increased its stake in clinical-stage drug developer Syntara to 19.24%, fresh off the commencement of a Phase 2a clinical study that has the potential to become a new treatment for patients diagnosed with myelofibrosis (bone marrow cancer). The combination
Read More
It is not just a tough environment for job seekers but also for job portals like SEEK (ASX: SEK), which are grappling with lowered ad revenue. In H1 FY24, SEEK reported a 5% decline in revenue compared to H1 FY23, totaling $596.8 million. EBITDA saw an 11% decline to $252.9 million, while net profit after
Read More
As more Aussies turn to streaming services, traditional TV networks like Seven West Media (ASX: SWM) are facing tough times. Less people are watching TV, which means less money spent on ads, hitting Seven’s finances hard. Last year, Australian TV ads dropped by 8%, while the total TV market declined by 9%, reflecting the trend
Read More
